A Gene Expression Signature of RAS Pathway Dependence Predicts Response to PI3K and RAS Pathway Inhibitors and Expands the Population of RAS Pathway Activated Tumors
BMC Medical Genomics - United Kingdom
doi 10.1186/1755-8794-3-26
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 30, 2010
Authors
Publisher
Springer Science and Business Media LLC